Haemonetics gains after CSL supply deal announcement
FROM THE WIRE · SEEKINGALPHA.COM
Haemonetics (HAE) stock jumps as CSL (CSLLY) plans to use the company's devices across all of its plasma collection centers this year. Read more here.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishCSL supply agreement for plasma collection devices represents positive commercial expansion.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01CSL announced plans to use Haemonetics devices across all its plasma collection centers.
- 02Implementation is planned for this year.
- 03The deal represents significant growth opportunity for Haemonetics.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets